Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$502,345
+$172,516 QoQ
Shares Held
53,842
+63.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#193
of 639 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Blueshift Asset Management, LLC holds $2,323,932 across 6 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (21.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
10,559 | $758,769 | |
| 2 | HLN |
Haleon plc
This page
|
53,842 | $502,345 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
5,837 | $275,914 | |
| 4 | VTRS |
Viatris Inc
|
17,236 | $273,707 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,615 | $257,996 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
471 | $255,201 |
All Filings in HLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $502,345 | 53,842 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $329,829 | 32,950 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $360,898 | 40,234 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||